Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bi-Profenid Non-inferiority Study in Acute Pain
NCT00810121Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketoprofen in acute pain (2 arms), sponsored by Sanofi. Primary endpoints: Resting pain intensity measured using the numeric scale (NS) at 5 days and Total intake of concomitant analgesics at 5 days. Started Nov 2008; status: completed.
02
Drugs
ketoprofen
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT00810121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00810121.